Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety, tolerability, and antivira activity of Epzicom in virologically controlled HIV subjects.

Phase 4

Therapeutic Concepts

Abacavir
Lamivudine